Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 Years.

Gadelha MR, Gordon MB, Doknic M, Mezősi E, Tóth M, Randeva H, Boguszewski CL, Davidson C, Casagrande A, Jochelson T, Krasner A

Open source

DOI: 10.1210/clinem/dgag254
Published: 2026 Jun 26
Container: The Journal of clinical endocrinology and metabolism
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1210/clinem/dgag254,
  title = {Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 Years.},
  author = {Gadelha MR and Gordon MB and Doknic M and Mezősi E and Tóth M and Randeva H and Boguszewski CL and Davidson C and Casagrande A and Jochelson T and Krasner A},
  year = {2026},
  journal = {The Journal of clinical endocrinology and metabolism},
  doi = {10.1210/clinem/dgag254},
  url = {https://doi.org/10.1210/clinem/dgag254}
}

RIS

TY  - JOUR
TI  - Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 Years.
AU  - Gadelha MR
AU  - Gordon MB
AU  - Doknic M
AU  - Mezősi E
AU  - Tóth M
AU  - Randeva H
AU  - Boguszewski CL
AU  - Davidson C
AU  - Casagrande A
AU  - Jochelson T
AU  - Krasner A
PY  - 2026
JO  - The Journal of clinical endocrinology and metabolism
DO  - 10.1210/clinem/dgag254
UR  - https://doi.org/10.1210/clinem/dgag254
ER  -

APA

MR, G., MB, G., M, D., E, M., M, T., H, R., CL, B., C, D., A, C., T, J., & A, K. (2026). Safety and Efficacy of Once-Daily Oral Paltusotine in Acromegaly: ACROBAT Advance Open-Label Extension Up to 4 Years.. The Journal of clinical endocrinology and metabolism. https://doi.org/10.1210/clinem/dgag254

Source records

pubmed · retrieved 2026-09-25T23:22:25.561Z